Concord Medical Services ... (CCM)
NYSE: CCM
· Real-Time Price · USD
5.19
-0.10 (-1.89%)
At close: Aug 15, 2025, 3:33 PM
5.19
0.00%
After-hours: Aug 15, 2025, 02:24 PM EDT
Concord Medical Services Income Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 109.41M | 109.41M | 126.44M | 126.44M | 142.26M | 142.26M | 163.91M | 163.91M | 72.13M | 72.13M | 146.37M | 146.37M | 96.44M | 96.44M |
Cost of Revenue | 130.2M | 130.2M | 146.04M | 146.04M | 160.97M | 160.97M | 195.75M | 195.75M | 116.5M | 116.5M | 176.01M | 176.01M | 95.25M | 95.25M |
Gross Profit | -20.8M | -20.8M | -19.59M | -19.59M | -18.71M | -18.71M | -31.84M | -31.84M | -44.37M | -44.37M | -29.64M | -29.64M | 1.19M | 1.19M |
Operating Income | -98.87M | -98.87M | -338.5M | -338.5M | 107.01M | 107.01M | -385.33M | -385.33M | -122.81M | -122.81M | -137.21M | -137.21M | -91.95M | -91.95M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -168.69M | -168.69M | -160.92M | -160.92M | -116.88M | -116.88M | -284.02M | -284.02M | -135.93M | -135.93M | -176.11M | -176.11M | -88.51M | -88.51M |
Net Income | -86.13M | -86.13M | -103.34M | -103.34M | -45.49M | -45.49M | -187.5M | -187.5M | -57.33M | -57.33M | -90.55M | -90.55M | -45.16M | -45.16M |
Selling & General & Admin | 78.07M | 78.07M | 104.89M | 104.89M | 88.3M | 88.3M | 107.88M | 107.88M | 78.44M | 78.44M | 107.57M | 107.57M | 93.14M | 93.14M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | 214.03M | 214.03M | -214.03M | -214.03M | 245.62M | 245.62M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 78.07M | 78.07M | 318.91M | 318.91M | -125.72M | -125.72M | 353.5M | 353.5M | 78.44M | 78.44M | 107.57M | 107.57M | 93.14M | 93.14M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 12.49M | 12.49M | 14.97M | 14.97M | 13.18M | 13.18M | 17.53M | 17.53M | 13.21M | 13.21M | 20M | 20M | 6.83M | 6.83M |
Cost & Expenses | 208.28M | 208.28M | 464.95M | 464.95M | 35.24M | 35.24M | 549.24M | 549.24M | 194.94M | 194.94M | 283.58M | 283.58M | 188.4M | 188.4M |
Income Tax Expense | 4.34M | 4.34M | 578K | 578K | 11.71M | 11.71M | 30.61M | 30.61M | 4.84M | 4.84M | 617K | 617K | 2.67M | 2.67M |
Shares Outstanding (Basic) | 145.6K | 145.6K | 145.23K | 145.23K | 145.6K | 145.6K | 145.37K | 145.37K | 145.6K | 145.6K | 36.1K | 36.1K | 39.67K | 39.67K |
Shares Outstanding (Diluted) | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K |
EPS (Basic) | -591.6 | -591.6 | -709.8 | -709.8 | -312.3 | -312.3 | -1.29K | -1.29K | -393.6 | -393.6 | -2.51K | -2.51K | -310.2 | -310.2 |
EPS (Diluted) | -591.6 | -591.6 | -711.6 | -711.6 | -312.3 | -312.3 | -1.29K | -1.29K | -393.6 | -393.6 | -2.51K | -2.51K | -1.14K | -1.14K |
EBITDA | -69.16M | -69.16M | -94.77M | -93.68M | -76.22M | -76.22M | -108.92M | -116.1M | -99.19M | -99.19M | -113.59M | -119.51M | -74.26M | -74.26M |
EBIT | -98.87M | -98.87M | -124.48M | -124.48M | -107.01M | -107.01M | -139.72M | -139.72M | -122.81M | -122.81M | -137.21M | -137.21M | -91.95M | -91.95M |
Depreciation & Amortization | 29.71M | 29.71M | 29.71M | 30.8M | 30.8M | 30.8M | 30.8M | 23.61M | 23.61M | 23.61M | 23.61M | 17.7M | 17.7M | 17.7M |